Generated: April 25, 2017
|Title:||Inhibitors of Bruton's tyrosine kinase|
|Abstract:||Disclosed herein are compounds of Formula (D) that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions. ##STR00001##|
|Inventor(s):||Honigberg; Lee (San Francisco, CA), Verner; Erik (Belmont, CA), Pan; Zhengying (Austin, TX)|
|Assignee:||PHARMACYCLICS LLC (Sunnyvale, CA)|
|Filing Date:||Nov 14, 2013|
|Claims:||1. A compound of Formula (D) having the structure: ##STR00058## wherein: L.sub.a is CH.sub.2, O, NH, or S; Ar is a substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl; Y is an optionally substituted group selected from among alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl; Z is C(.dbd.O), OC(.dbd.O), NHC(.dbd.O), C(.dbd.S), S(.dbd.O).sub.x, OS(.dbd.O).sub.x, or NHS(.dbd.O).sub.x, where x is 1 or 2; R.sub.7 is H, substituted or unsubstituted C.sub.1-C.sub.4alkyl, substituted or unsubstituted C.sub.1-C.sub.4heteroalkyl, substituted or unsubstituted C.sub.3-C.sub.6cycloalkyl, or substituted or unsubstituted C.sub.2-C.sub.6heterocycloalkyl; R.sub.8 is H, substituted or unsubstituted C.sub.1-C.sub.4alkyl, substituted or unsubstituted C.sub.1-C.sub.4heteroalkyl, substituted or unsubstituted C.sub.3-C.sub.6cycloalkyl, or substituted or unsubstituted C.sub.2-C.sub.6heterocycloalkyl; or R.sub.7 and R.sub.8 taken together form a bond; R.sub.6 is H, substituted or unsubstituted C.sub.1-C.sub.4alkyl, substituted or unsubstituted C.sub.1-C.sub.4heteroalkylene, C.sub.1-C.sub.6alkoxyalkyl, C.sub.1-C.sub.8alkylaminoalkyl, substituted or unsubstituted C.sub.3-C.sub.6cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted C.sub.2-C.sub.8heterocycloalkyl, substituted or unsubstituted heteroaryl, C.sub.1-C.sub.4alkyl(aryl), C.sub.1-C.sub.4alkyl(heteroaryl), C.sub.1-C.sub.4alkyl(C.sub.3-C.sub.8cycloalkyl), or C.sub.1-C.sub.4alkyl(C.sub.2-C.sub.8heterocycloalkyl); or a pharmaceutically acceptable solvate or pharmaceutically acceptable salt thereof; wherein one or more hydrogen atoms are replaced with deuterium. |
2. A compound having the structure: ##STR00059## or a pharmaceutically acceptable solvate or pharmaceutically acceptable salt thereof; wherein one or more hydrogen atoms are replaced with deuterium.
3. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 or 2, and a pharmaceutically acceptable excipient.
4. The pharmaceutical composition of claim 3 that is formulated for a route of administration selected from oral administration, parenteral administration, buccal administration, nasal administration, topical administration, or rectal administration.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.